Supplement firm gets warning letter for selling SARMs products that resulted in jail time for another marketer
Another supplement manufacturer has been cited for sales of SARMs, a category of ingredients that FDA has warned consumers about.
Archives for July 12, 2022
Researchers find strong evidence for prenatal vitamins, but find few products that meet recommendations
A new review has found strong support for the use of many vitamins and other dietary ingredients in prenatal supplements. But the researches also found that few supplements marketed to expectant mothers meet their recommended dosage levels.
Countdown to Beauty-from-Within Webinar
We’re just days away from our beauty-from-within webinar and our expert panel is ready to dig into the latest in ingredients, products and research.
MycoTechnology leverages mycelial fermentation to unlock plant proteins
A patented mushroom mycelia fermentation platform is paving the way to next-gen plant proteins, according to a recent animal study.
Japan focus: FFCs exclusive market analysis, Asahi’s paraprobiotic RCT, government-funded survey findings
Japan’s Foods with Function Claims (FFCs) exclusive market analysis, Asahi’s research on paraprobiotic benefits for alleviating menopause, and results from a government-funded survey in school children’s diet are some of the stories covered in this news...
トレンドトラッカー：日本のFFC市場分析、ビーガンフレンドリーなオメガ3への需要、Growth Asia Summit
日本の機能性表示食品（FFC）の動向、Thai Unionの知見に基づくビーガン対応オメガ3の需要、シンガポールで開催される健康・栄養業界向けビジネスサミットを紹介します。
サイエンス ショート：クルクミン－ピペリンとCOVID-19、プレバイオティクスとしてのケール副産物など
この特集では、COVID-19患者の衰弱を軽減するクルクミン-ピペリンサプリメントの利点、シンガポールの研究者がケールの茎をプレバイオティクスにアップサイクルする方法など、アジア太平洋地域の健康と栄養産業における最新の科学的知見を紹介します。
ジャパン フォーカス：FFC独占データによる市場分析、アサヒのパラプロバイオティックス－RCT、政府出資の調査結果
このニュースでは、日本の機能性表示食品（FFC）の独占データによる市場分析、アサヒの更年期障害緩和のためのパラプロバイオティクスに関する研究、政府による児童の食生活に関する調査の結果などを紹介します。
チャイナ ラウンドアップ：BuffXの中医学イノベーション、JD618の売上データ、Chromadexのオムニチャネルリテール計画
中国健康・栄養業界のニュースとして、機能性グミメーカー BuffXによる中医学ベースの機能性食品の計画、JDの618オンラインショッピングイベントで最も売れた栄養製品、Chromadexのオムニチャネルリテール計画などを紹介します。
ブランニュー：米国の粉ミルク不足、Nestle Health Science社の買収、Regenosis 社に注目
Bubs Australia社やBellamy's Organic社が米国の粉ミルク市場への参入に成功した経緯や、Nestle Health Scienceの最新の買収など、健康・栄養業界におけるブランドの動向を紹介します。
EC allows turmeric-based metabolite onto market as Novel Food
The European Commission (EC) is to allow a turmeric-based metabolite on the market as a Novel Food (NF) for 5 years in a move that raises questions about other curcuminoid extracts.
Most people in EU read labels and take supplements safely
Most adults safely consume food supplements, according to new research in the European Union.
Vitamin D may help reduce eczema in early infancy
Routine vitamin D supplementation during pregnancy can reduce incidence of atopic eczema in the first year of life, according to researchers at the University of Southampton.
Brand new: US formula shortage, Nestle Health Science’s acquisition, Regenosis in focus
This round-up will look at developments of brands in the health and nutrition industry, including how brands such as Bubs Australia and Bellamy’s Organic have successfully gained access to the infant formula market in US, as well as Nestle Health...
Japan’s FFC functionalities: Immune health category dominated by Kirin in FY21, cognitive claims under fire
Kirin has dominated Japan’s Foods with Function Claims (FFC) immune health category in FY21, with it being the only company that has received the authority’s recognition for its immune health ingredient L. lactis strain Plasma – also known as LC-plasma.
Bugging the question: Asia insect protein sector cite upscaling and negative preconceptions as biggest hurdles
Insect protein sector pioneers in Asia have cited both negative consumer perceptions as well as upscaling challenges as the most major hurdles the industry is currently facing in its battle to go mainstream.
Regulators failing to match consumer demand for natural products supporting mental well-being – Watch
Our first Mind and Mood Interactive Broadcast has heard that regulators are failing to match consumer demand for natural products to aid mental well-being spanning cognition, sleep, stress and anxiety in the wake of the COVID-19 pandemic.